对于小儿血液恶性瘤中血小板缺血的血栓蛋白质受体激活剂
Amanda E Marinoff1, Allyson Thrall1, Kathryn Aaronson1
1Department of Pediatrics, Benioff Children's Hospitals, University of California, San Francisco, California, USA.
Pediatric blood & cancer
|January 9, 2025
概括
血栓形成素受体激动剂 (TPO-RAs) 在患有血液恶性瘤的儿科和年轻成人患者中有效提高了血小板计数并减少了输血,显示出有利的安全性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 儿科医学 儿科医学
背景情况:
- 血栓形成素受体激动剂 (TPO-RAs) 用于成年人的血栓缩症.
- 关于TPO-RA在儿科,青少年和年轻成人 (AYA) 患有血液恶性瘤的患者的安全性和疗效的数据有限.
研究的目的:
- 评估TPO-RAs在患有血液恶性瘤的儿科和AYA患者的安全性和有效性.
主要方法:
- 对15名儿科和AYA患者 (≤25岁) 进行了回顾性研究,这些患者患有血液性恶性瘤,并接受TPO-RAs治疗.
- 血小板计数和输血需求在TPO-RA治疗前后的比较.
主要成果:
- 中位数血小板数显著增加,从24增加到54×109/L (p=0.029).
- 每月的血小板输血从中位数15下降到2个单位 (p=0.007).
- 93%的人在8周内达到持续的血小板计数>50,000/μL;没有观察到任何不良事件.
结论:
- 在患有血液性恶性瘤的儿科和AYA患者中,TPO-RAs对耐火性血小板缺血是有效的.
- 观察到有利的安全概况,即使是伴随疾病.
- 进一步的前性试验是有必要的,以建立指导方针.
相关概念视频
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Bone Marrow Sampling and Transplants
279
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
279
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


